Sunkwan Properties Group Limited is a limited company that was established on February 27, 2019. The company obtained its business license from the Suzhou Market Supervision Administration on the same day. The company's main business scope is research and development of new drugs, as well as related technical consulting and services. The company was originally established in March 2009 with a registered capital of $147,000 and was located in Kunshan City, Jiangsu Province. On January 14, 2019, the company changed its name to Suzhou Sunkwan Pharmaceutical Co., Ltd. The company's net assets, as audited by Xinyong Zhonghe, were 237.53 million yuan as of December 31, 2018. The company completed its capital contribution from all shareholders as of February 23, 2019. On February 27, 2019, the company underwent a complete transformation and obtained a new business license from the Suzhou Market Supervision Administration. The company's unified social credit code is 91320583685894616H. The Kunshan High-tech Zone Investment Promotion Service Bureau also recorded the company's transformation into a limited company.
Headquarters
8/F, Tower 5, No. 1399 Xinzhen Road, Minhang District
Shanghai; Shanghai;
Contact Details: Purchase the Sunkwan Properties Group Limited (Hong Kong) report to view the information.
Website: http://www.sunkwan.com.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service